DUBLIN, Calif., Oct. 3 /PRNewswire-FirstCall/ -- SuperGen Inc. , a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today announced that James S. Manuso, Ph.D., President and Chief Executive Officer is scheduled to present at the BIO InvestorForum on October 10, 2007, at The Palace Hotel in San Francisco.
SuperGen’s presentation at the BIO InvestorForum is scheduled to begin at 1:45 p.m. PDT. A live webcast of the presentation will be available on the investor relations section of the Company’s Web site at www.supergen.com. The webcast will be archived for 90 days.
About SuperGen
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.
tenns@supergen.com E-mail: mary.vegh@supergen.com
CONTACT: Timothy L. Enns, SVP, Corporate Communications & Business
Development, +1-925-560-0100, tenns@supergen.com, Mary M. Vegh Manager,
Investor Relations, +1-925-560-2845
Web site: http://www.supergen.com/
